Analysis of the prescription process of PCSK9 inhibitors in the cardiology departments of Spanish hospitals and optimization proposal. The IKIGAI study Vivencio Barrios; Carlos Escobar; Vicente Arrarte; Marisol Bravo; Alfredo del Campo; Rafael Hidalgo; Lluís Recasens; Ángel Cequier;

Efficacy and safety of PCSK9 inhibitors in real life Antón González-Guerrero; Eugenia Navarrete-Rouco; David Benaiges; Eva Giralt-Steinhauer; Lidia Marcos; Anna Oliveras; Lluis Recasens; Juan Pedro-Botet;

Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;